{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T11:53:20Z","timestamp":1769082800437,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T00:00:00Z","timestamp":1260144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T00:00:00Z","timestamp":1260144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2010,3,18]]},"DOI":"10.1038\/onc.2009.452","type":"journal-article","created":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T15:57:51Z","timestamp":1260201471000},"page":"1588-1597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity"],"prefix":"10.1038","volume":"29","author":[{"given":"M-C","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Kozlowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D N","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Meyerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D J","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K-K","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,7]]},"reference":[{"key":"BFonc2009452_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/01.ju.0000074621.74361.10","volume":"170","author":"H Adachi","year":"2003","unstructured":"Adachi H, Igawa M, Shiina H, Urakami S, Shigeno K, Hino O . (2003). Human bladder tumors with 2-hit mutations of tumor suppressor gene TSC1 and decreased expression of p27. J Urol 170: 601\u2013604.","journal-title":"J Urol"},{"key":"BFonc2009452_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.biochem.75.103004.142702","volume":"75","author":"DR Alessi","year":"2006","unstructured":"Alessi DR, Sakamoto K, Bayascas JR . (2006). LKB1-dependent signaling pathways. Annu Rev Biochem 75: 137\u2013163.","journal-title":"Annu Rev Biochem"},{"key":"BFonc2009452_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa063564","volume":"358","author":"JJ Bissler","year":"2008","unstructured":"Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM et al. (2008). Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 358: 140\u2013151.","journal-title":"N Engl J Med"},{"key":"BFonc2009452_CR4","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1056\/NEJMra0707704","volume":"358","author":"F Ciardiello","year":"2008","unstructured":"Ciardiello F, Tortora G . (2008). EGFR antagonists in cancer treatment. N Engl J Med 358: 1160\u20131174.","journal-title":"N Engl J Med"},{"key":"BFonc2009452_CR5","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1101\/gad.1199104","volume":"18","author":"MN Corradetti","year":"2004","unstructured":"Corradetti MN, Inoki K, Bardeesy N, DePinho RA, Guan KL . (2004). Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev 18: 1533\u20131538.","journal-title":"Genes Dev"},{"key":"BFonc2009452_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP . (2006). The tuberous sclerosis complex. N Engl J Med 355: 1345\u20131356.","journal-title":"N Engl J Med"},{"key":"BFonc2009452_CR7","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature07423","volume":"455","author":"L Ding","year":"2008","unstructured":"Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K et al. (2008). Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455: 1069\u20131075.","journal-title":"Nature"},{"key":"BFonc2009452_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1634\/theoncologist.2007-0171","volume":"13","author":"C Gridelli","year":"2008","unstructured":"Gridelli C, Maione P, Rossi A . (2008). The potential role of mTOR inhibitors in non-small cell lung cancer. Oncologist 13: 139\u2013147.","journal-title":"Oncologist"},{"key":"BFonc2009452_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","volume":"12","author":"DA Guertin","year":"2007","unstructured":"Guertin DA, Sabatini DM . (2007). Defining the role of mTOR in cancer. Cancer Cell 12: 9\u201322.","journal-title":"Cancer Cell"},{"key":"BFonc2009452_CR10","first-page":"48","volume":"21","author":"DG Hardie","year":"2006","unstructured":"Hardie DG, Sakamoto K . (2006). AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda) 21: 48\u201360.","journal-title":"Physiology (Bethesda)"},{"key":"BFonc2009452_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1083\/jcb.200403069","volume":"166","author":"LS Harrington","year":"2004","unstructured":"Harrington LS, Findlay GM, Gray A, Tolkacheva T, Wigfield S, Rebholz H et al. (2004). The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 166: 213\u2013223.","journal-title":"J Cell Biol"},{"key":"BFonc2009452_CR12","first-page":"400","volume":"59","author":"EP Henske","year":"1996","unstructured":"Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N et al. (1996). Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 59: 400\u2013406.","journal-title":"Am J Hum Genet"},{"key":"BFonc2009452_CR13","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1038\/sj.onc.1202854","volume":"18","author":"N Hornigold","year":"1999","unstructured":"Hornigold N, Devlin J, Davies AM, Aveyard JS, Habuchi T, Knowles MA . (1999). Mutation of the 9q34 gene TSC1 in sporadic bladder cancer. Oncogene 18: 2657\u20132661.","journal-title":"Oncogene"},{"key":"BFonc2009452_CR14","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1128\/MCB.00289-08","volume":"28","author":"J Huang","year":"2008","unstructured":"Huang J, Dibble CC, Matsuzaki M, Manning BD . (2008). The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol 28: 4104\u20134115.","journal-title":"Mol Cell Biol"},{"key":"BFonc2009452_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"412","author":"J Huang","year":"2008","unstructured":"Huang J, Manning BD . (2008). The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 412: 179\u2013190.","journal-title":"Biochem J"},{"key":"BFonc2009452_CR16","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1101\/gad.943001","volume":"15","author":"EL Jackson","year":"2001","unstructured":"Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R et al. (2001). Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15: 3243\u20133248.","journal-title":"Genes Dev"},{"key":"BFonc2009452_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. (2008). Cancer statistics, 2008. CA Cancer J Clin 58: 71\u201396.","journal-title":"CA Cancer J Clin"},{"key":"BFonc2009452_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nature06030","volume":"448","author":"H Ji","year":"2007","unstructured":"Ji H, Ramsey MR, Hayes DN, Fan C, McNamara K, Kozlowski P et al. (2007). LKB1 modulates lung cancer differentiation and metastasis. Nature 448: 807\u2013810.","journal-title":"Nature"},{"key":"BFonc2009452_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1203\/01.PDR.0000147727.78571.07","volume":"57","author":"H Kenerson","year":"2005","unstructured":"Kenerson H, Dundon TA, Yeung RS . (2005). Effects of rapamycin in the Eker rat model of tuberous sclerosis complex. Pediatr Res 57: 67\u201375.","journal-title":"Pediatr Res"},{"key":"BFonc2009452_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00439-006-0308-9","volume":"121","author":"P Kozlowski","year":"2007","unstructured":"Kozlowski P, Roberts P, Dabora S, Franz D, Bissler J, Northrup H et al. (2007). Identification of 54 large deletions\/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Hum Genet 121: 389\u2013400.","journal-title":"Hum Genet"},{"key":"BFonc2009452_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","volume":"11","author":"DJ Kwiatkowski","year":"2002","unstructured":"Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, el-Hashemite N et al. (2002). A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum Mol Genet 11: 525\u2013534.","journal-title":"Hum Mol Genet"},{"key":"BFonc2009452_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/gcc.20118","volume":"42","author":"L Lee","year":"2005","unstructured":"Lee L, Sudentas P, Donohue B, Asrican K, Worku A, Walker V et al. (2005). Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models. Genes Chromosomes Cancer 42: 213\u2013227.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFonc2009452_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ccr.2007.06.005","volume":"12","author":"D Li","year":"2007","unstructured":"Li D, Shimamura T, Ji H, Chen L, Haringsma HJ, McNamara K et al. (2007). Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy. Cancer Cell 12: 81\u201393.","journal-title":"Cancer Cell"},{"key":"BFonc2009452_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","volume":"121","author":"L Ma","year":"2005","unstructured":"Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP . (2005). Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121: 179\u2013193.","journal-title":"Cell"},{"key":"BFonc2009452_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1378\/chest.07-0898","volume":"133","author":"FX McCormack","year":"2008","unstructured":"McCormack FX . (2008). Lymphangioleiomyomatosis: a clinical update. Chest 133: 507\u2013516.","journal-title":"Chest"},{"key":"BFonc2009452_CR26","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","volume":"28","author":"L Meikle","year":"2008","unstructured":"Meikle L, Pollizzi K, Egnor A, Kramvis I, Lane H, Sahin M et al. (2008). Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci 28: 5422\u20135432.","journal-title":"J Neurosci"},{"key":"BFonc2009452_CR27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/cncr.22816","volume":"110","author":"DT Milton","year":"2007","unstructured":"Milton DT, Riely GJ, Azzoli CG, Gomez JE, Heelan RT, Kris MG et al. (2007). Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer. Cancer 110: 599\u2013605.","journal-title":"Cancer"},{"key":"BFonc2009452_CR28","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","volume":"83","author":"JR Molina","year":"2008","unstructured":"Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA . (2008). Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83: 584\u2013594.","journal-title":"Mayo Clin Proc"},{"key":"BFonc2009452_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/00000478-199804000-00012","volume":"22","author":"TE Muir","year":"1998","unstructured":"Muir TE, Leslie KO, Popper H, Kitaichi M, Gagne E, Emelin JK et al. (1998). Micronodular pneumocyte hyperplasia. Am J Surg Pathol 22: 465\u2013472.","journal-title":"Am J Surg Pathol"},{"key":"BFonc2009452_CR30","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.1158\/1078-0432.CCR-09-0898","volume":"15","author":"FM Platt","year":"2009","unstructured":"Platt FM, Hurst CD, Taylor CF, Gregory WM, Harnden P, Knowles MA . (2009). Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer. Clin Cancer Res 15: 6008\u20136017.","journal-title":"Clin Cancer Res"},{"key":"BFonc2009452_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1476-4598-8-38","volume":"8","author":"K Pollizzi","year":"2009","unstructured":"Pollizzi K, Malinowska-Kolodziej I, Stumm M, Lane H, Kwiatkowski D . (2009). Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis. Mol Cancer 8: 38.","journal-title":"Mol Cancer"},{"key":"BFonc2009452_CR32","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1074\/jbc.270.2.815","volume":"270","author":"CJ Sabers","year":"1995","unstructured":"Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, Wiederrecht G et al. (1995). Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J Biol Chem 270: 815\u2013822.","journal-title":"J Biol Chem"},{"key":"BFonc2009452_CR33","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1038\/sj.onc.1210594","volume":"26","author":"M Sanchez-Cespedes","year":"2007","unstructured":"Sanchez-Cespedes M . (2007). A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 26: 7825\u20137832.","journal-title":"Oncogene"},{"key":"BFonc2009452_CR34","first-page":"105","volume":"1654","author":"M Santarosa","year":"2004","unstructured":"Santarosa M, Ashworth A . (2004). Haploinsufficiency for tumour suppressor genes: when you don\u2019t need to go all the way. Biochim Biophys Acta 1654: 105\u2013122.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc2009452_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2004.06.007","volume":"6","author":"RJ Shaw","year":"2004","unstructured":"Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, DePinho RA et al. (2004). The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6: 91\u201399.","journal-title":"Cancer Cell"},{"key":"BFonc2009452_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.canlet.2005.08.015","volume":"240","author":"LB Smilenov","year":"2006","unstructured":"Smilenov LB . (2006). Tumor development: haploinsufficiency and local network assembly. Cancer Lett 240: 17\u201328.","journal-title":"Cancer Lett"},{"key":"BFonc2009452_CR37","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0002-9440(10)63041-6","volume":"159","author":"K Takamochi","year":"2001","unstructured":"Takamochi K, Ogura T, Suzuki K, Kawasaki H, Kurashima Y, Yokose T et al. (2001). Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung. Am J Pathol 159: 1941\u20131948.","journal-title":"Am J Pathol"},{"key":"BFonc2009452_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/ng1975","volume":"39","author":"RK Thomas","year":"2007","unstructured":"Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM et al. (2007). High-throughput oncogene mutation profiling in human cancer. Nat Genet 39: 347\u2013351.","journal-title":"Nat Genet"},{"key":"BFonc2009452_CR39","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nature06358","volume":"450","author":"BA Weir","year":"2007","unstructured":"Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R et al. (2007). Characterizing the cancer genome in lung adenocarcinoma. Nature 450: 893\u2013898.","journal-title":"Nature"},{"key":"BFonc2009452_CR40","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1158\/0008-5472.CAN-04-4420","volume":"65","author":"M Wislez","year":"2005","unstructured":"Wislez M, Spencer ML, Izzo JG, Juroske DM, Balhara K, Cody DD et al. (2005). Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras. Cancer Res 65: 3226\u20133235.","journal-title":"Cancer Res"},{"key":"BFonc2009452_CR41","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1172\/JCI200317222","volume":"112","author":"H Zhang","year":"2003","unstructured":"Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, Bajraszewski N et al. (2003). Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223\u20131233.","journal-title":"J Clin Invest"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2009452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009452","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T17:46:05Z","timestamp":1647884765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2009452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,7]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,3,18]]}},"alternative-id":["BFonc2009452"],"URL":"https:\/\/doi.org\/10.1038\/onc.2009.452","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,7]]},"assertion":[{"value":"30 July 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}